TCTR20201125004招募中不适用
A Prospective Comparative Study of Posterior Vitreous Detachment in Glaucoma Patients and Controls
Sukhumal Thanapaisal0 个研究点开始时间: 2020年11月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Glaucoma group
- •1.Diagnosed glaucoma
- •2.Age 18-60 years old
- •3.Given informed consent
- •Normal group
- •1.Non-glaucoma
- •2.Age 18-60 years old
- •3.Given informed consent
排除标准
- •1 Narrow angle or appositional angle closure
- •2 Previous intraocular surgery
- •3 Previous intravitreous injection
- •4 History of ocular trauma
- •5.History of vitreoretinal disease
- •6.History of uveitis
- •7.Refractive error equal or more than 3 diopters
- •8.Cannot provide wide field-OCT image
研究者
相似试验
已完成
不适用
Progression of posterior vitreous detachment (PVD) after cataract surgery in non-highly myopic patientscataract, posterior vitreous detachmentJPRN-UMIN000042994Hayashi Eye Hospital250
已完成
不适用
Evaluation of treatment options of central serous chorioretinopathyCentral Serous Chorioretinoathy.Central Serous ChorioretinopathyIRCT2017041533448N1Vice chancellor for research, Zahedan University of Medical Sciences30
招募中
2 期
Comparative study of the effect of intravitreal injection of bevacizumab versus simultaneous intravitreal injection of bevacizumab and triamcinolone acetonideRetinal vascular occlusions.Retinal vascular occlusionsIRCT20130812014333N185Kermanshah University of Medical Sciences58
招募中
3 期
Evaluation of the evolution of patients with vitreous hemorrhage caused by proliferative diabetic retinopathy subjected to intravitreal injection of antivascular endothelial growth factor (bevacizumab)vitreous hemorrhageACTRN12618000697280Hospital Oftalmológico de Sorocaba60
招募中
4 期
observational comparative study: Intravitreal treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) with a bispecific antibody Vabysmo® (faricimab) vs. a classical anti-VEGF inhibitor Eylea® (aflibercept) in a treat-and-extend-regimen (FATE).H35.30H36.0Diabetic retinopathyDRKS00031548Augenklinik der Medizinischen Hochschule Hannover136